Charles River Laboratories (CRL) Tops Q1 EPS by 2c, Reaffirms 2019 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Charles River Laboratories (CRL) Tops Q1 EPS by 2c, Reaffirms 2019 Guidance

Charles River Laboratories Announces First-Quarter 2019 Results

May 7, 2019 7:00 AM EDT

First-Quarter Revenue of $604.6 Million

First-Quarter GAAP Earnings per Share of $1.11 and Non-GAAP Earnings per Share of $1.40

Reaffirms 2019 Guidance Including Citoxlab

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2019. For the quarter, revenue was $604.6 million, an increase of 22.4% from $494.0 million in the first quarter of 2018. Revenue growth was driven by all three business segments, particularly Discovery and Safety Assessment and Manufacturing Support.

Acquisitions, principally MPI Research, contributed 14.4% to consolidated first-quarter revenue... More